AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 184 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $276,000 | +37.3% | 9,338 | +185.7% | 0.18% | +108.0% |
| Q3 2018 | $201,000 | -9.9% | 3,269 | -20.5% | 0.09% | +63.0% |
| Q1 2018 | $223,000 | -37.2% | 4,112 | -43.7% | 0.05% | -46.5% |
| Q3 2017 | $355,000 | -43.7% | 7,300 | -39.2% | 0.10% | -53.7% |
| Q2 2017 | $631,000 | +45.7% | 12,000 | +25.5% | 0.22% | +23.2% |
| Q1 2017 | $433,000 | +78.9% | 9,558 | +49.3% | 0.18% | +39.4% |
| Q4 2016 | $242,000 | – | 6,400 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |